Controlling the cost of personalized medicine: The latest from Business of Biotech goes behind the scenes of building a system that simplifies production and reduces the cost of non-viral T cell therapies with Ziopharm Oncology CEO Laurence Cooper, M.D., Ph.D. Listen now and subscribe so you never miss an episode.
By Dr. Deanna Mudie, Dr. Kimberly Shepard, Dr. Michael Morgen, John Baumann,Lonza - API
This poster outlines a novel engineered platform for the formulation of high-active-loading oral solid dosage forms containing amorphous solid dispersions (ASDs) of a rapidly crystallizing drug with a low glass-transition temperature (Tg).
Technical improvements related to cryogenic electron microscopy (cryo-EM) have triggered a revolution in structural biology and made single-particle cryo-EM the dominant discipline for determining structures. Cryo-EM has opened new opportunities to determine large and complex molecules but has also introduced new challenges for the purification of samples.
Life Science Leader Magazine
Have you heard of Life Science Leader? Check it out today for access to candid interviews with top-tier executives on how they do business.